617 related articles for article (PubMed ID: 22179105)
1. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
[TBL] [Abstract][Full Text] [Related]
2. Modeling induced pluripotent stem cells from fibroblasts of Duchenne muscular dystrophy patients.
Luo Y; Fan Y; Chen X; Yue L; Yu B; Li Q; Chen Y; Sun X
Int J Neurosci; 2014 Jan; 124(1):12-21. PubMed ID: 23528047
[TBL] [Abstract][Full Text] [Related]
3. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
5. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
Lee Y; Jeong D; Ham S; Son J; Ko K
Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
7. Inducing Pluripotency in the Domestic Cat (
Dutton LC; Dudhia J; Guest DJ; Connolly DJ
Stem Cells Dev; 2019 Oct; 28(19):1299-1309. PubMed ID: 31389301
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
9. Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research.
Yagi T; Kosakai A; Ito D; Okada Y; Akamatsu W; Nihei Y; Nabetani A; Ishikawa F; Arai Y; Hirose N; Okano H; Suzuki N
PLoS One; 2012; 7(7):e41572. PubMed ID: 22848530
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
[TBL] [Abstract][Full Text] [Related]
11. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
[TBL] [Abstract][Full Text] [Related]
12. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.
Abujarour R; Bennett M; Valamehr B; Lee TT; Robinson M; Robbins D; Le T; Lai K; Flynn P
Stem Cells Transl Med; 2014 Feb; 3(2):149-60. PubMed ID: 24396035
[TBL] [Abstract][Full Text] [Related]
13. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
14. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts.
Vermilyea SC; Guthrie S; Meyer M; Smuga-Otto K; Braun K; Howden S; Thomson JA; Zhang SC; Emborg ME; Golos TG
Stem Cells Dev; 2017 Sep; 26(17):1225-1235. PubMed ID: 28635509
[TBL] [Abstract][Full Text] [Related]
15. Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Reiter I; Ramchandren S; Arad M; Michele DE; Binah O
Stem Cell Res; 2018 May; 29():111-114. PubMed ID: 29653394
[TBL] [Abstract][Full Text] [Related]
16. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
[TBL] [Abstract][Full Text] [Related]
17. Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.
Breton A; Sharma R; Diaz AC; Parham AG; Graham A; Neil C; Whitelaw CB; Milne E; Donadeu FX
Stem Cells Dev; 2013 Feb; 22(4):611-21. PubMed ID: 22897112
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
20. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
